CRIS Current Research Information System

GRAZI, GIAN LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10347
EU - Europa 6564
AS - Asia 2592
AF - Africa 442
SA - Sud America 22
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19982
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10324
GB - Regno Unito 2503
VN - Vietnam 1026
CN - Cina 1007
SE - Svezia 960
DE - Germania 805
UA - Ucraina 619
IT - Italia 598
IN - India 444
FR - Francia 374
RU - Federazione Russa 320
EE - Estonia 194
ZA - Sudafrica 186
TG - Togo 180
BE - Belgio 42
JP - Giappone 41
SC - Seychelles 38
NG - Nigeria 36
IR - Iran 33
GR - Grecia 26
CA - Canada 23
CH - Svizzera 21
RO - Romania 20
NL - Olanda 18
LB - Libano 13
ES - Italia 12
HR - Croazia 11
BR - Brasile 10
CL - Cile 8
FI - Finlandia 7
UZ - Uzbekistan 7
AU - Australia 6
EU - Europa 6
BG - Bulgaria 5
PL - Polonia 5
AT - Austria 4
HK - Hong Kong 4
PT - Portogallo 4
DK - Danimarca 3
IE - Irlanda 3
NO - Norvegia 3
PE - Perù 3
TR - Turchia 3
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
ID - Indonesia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
Totale 19982
Salva come PNG Salva come JPEG
Città #
Southend 2290
Fairfield 1856
Chandler 1018
Woodbridge 895
Wilmington 790
Ashburn 789
Seattle 767
Houston 739
Dong Ket 676
Cambridge 618
Princeton 552
Ann Arbor 474
Jacksonville 400
Westminster 251
Nanjing 223
Padova 214
Berlin 181
Lomé 180
Saint Petersburg 132
Bologna 107
San Diego 103
Jinan 96
Shenyang 96
Hebei 71
Nanchang 70
Dearborn 67
Des Moines 63
Changsha 60
Beijing 59
Boardman 48
Norwalk 47
Jiaxing 43
Tianjin 43
Brussels 41
Milan 41
Falls Church 40
Mahé 38
Medford 37
Abeokuta 36
Tokyo 35
Verona 34
Haikou 28
Redwood City 28
Zhengzhou 28
Guangzhou 26
Bremen 25
Redmond 22
Ningbo 21
Taiyuan 20
Monmouth Junction 17
Hangzhou 16
Lanzhou 15
Leawood 15
Paris 15
Toronto 15
Taizhou 13
Ardabil 11
Fuzhou 11
Kunming 11
San Francisco 10
Frankfurt Am Main 9
Groningen 9
Phoenix 9
Plauen 9
Hefei 8
São Paulo 8
Zanjan 8
Buffalo 7
Frankfurt am Main 7
Helsinki 7
Madrid 7
Provo 7
Sacramento 7
Chicago 6
Lausanne 6
Muizenberg 6
Orange 6
Andover 5
Fremont 5
Giardinello 5
Henderson 5
New York 5
North Bergen 5
San Venanzo 5
Sofia 5
Ulan-ude 5
Amsterdam 4
Caserta 4
Changchun 4
Costa Mesa 4
Den Haag 4
Hanover 4
Kiev 4
Las Vegas 4
London 4
Reggio Nell'emilia 4
Rome 4
Shanghai 4
Augusta 3
Castelnuovo Don Bosco 3
Totale 14892
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 175
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 173
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 165
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 158
A new liver transplant priority for patients with hepatocellular carcinoma. 156
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 156
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 151
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 149
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 148
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 148
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 147
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 146
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 137
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 132
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 130
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 127
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 127
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 125
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 125
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 125
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 125
The peculiar aging of human liver: A geroscience perspective within transplant context 121
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 120
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 120
Lifelong maintenance of composition, function and cellular/subcellular distribution of proteasomes in human liver 119
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 117
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 117
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 114
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 113
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 113
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 112
Split-liver transplantation with pediatric donors: a multicenter experience. 112
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 112
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. 111
Efficacy of MELD score in predicting survival after liver retransplantation. 111
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 111
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 111
ALPPS for primary and secondary liver tumors 111
Coping strategies in intestinal transplantation 111
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 110
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 110
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 110
Using Elderly Donors in Liver Transplantation. 109
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 108
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 106
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 106
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 106
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. 105
Survival Benefit After Liver Transplantation: A Single European Center Experience 104
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 104
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic Hepatitis C virus infection 104
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 103
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 102
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 100
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. 100
Kidney transplantation combined with other organs in bologna: an update. 100
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 100
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 100
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 100
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 99
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 98
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 97
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 97
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 97
Successful treatment of rhinomaxillary form of mucormycosis infection after liver transplantation: a case report 96
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 96
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 96
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 95
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 95
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 95
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 94
Can Hepatocellular Carcinoma tumor grade and microscopical vascular invasion be predicted with an artificial neural network? 94
The role of liver resections for metastases from lung carcinoma. 93
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 92
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 91
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 91
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 91
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 91
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 90
Modification of Acid-Base Balance in Cirrhotic Patients Undergoing Liver Resection for Hepatocellular Carcinoma. 89
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 89
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens 89
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. 89
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 89
Liver and partial atrium transplantation for chronic Budd-Chiari syndrome. 88
null 88
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 87
Two years Mycophenolate Mofetil plus low dose calcineurin inhibitor for renal dysfunction after liver transplantation. 87
17. Other Malignant Primary Tumors of the Liver 87
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 87
Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. 86
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 86
Liver transplantation for benign hepatic tumors: A systematic review 86
Impact of biliary complications in right lobe living donor liver transplantation. 86
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 86
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection. 85
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 85
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach 85
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 85
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 85
Totale 10880
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018470 0000 00 02 314568
2018/20191766 6820073236 39215 8064 140273129249
2019/20206984 99015585404 721758 894921 974470256356
2020/20213702 787296125188 74162 92169 2781961761159
2021/20224519 445183348399 413247 100307 135244931767
2022/20232925 526754253633 264340 1550 0000
Totale 20477